With over two decades of experience in adoptive cell therapy, Ryan is a seasoned specialist in designing, testing, and manufacturing personalized medicines through the initiation and delivery of multiple clinical trials across liquid & solid cancers.

Ryan’s career reflects a dedication to societal impact through innovative solutions in the healthcare sector. He has held multiple strategic leadership roles, driving multi-disciplinary teams while navigating complex regulatory landscapes. With a track record in process development and industrialization, he excels in expediting ATMP development for companies.